Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Mirati (MRTX) Down 23% on Mixed Data From Lung Cancer Study
06:39pm, Friday, 27'th May 2022 Zacks Investment Research
Mirati (MRTX) posts positive data from a phase II study evaluating its lung cancer candidate adagrasib. However, the drug caused side-effects in a large number of study participants.
Why This Fast-Growing Dividend Stock Is a Buy
02:45pm, Friday, 27'th May 2022 The Motley Fool
Merck's market-topping 3% dividend yield isn't the sole reason to buy shares.
Exelixis (EXEL) Announces Results From Phase II HNSCC Study
02:10pm, Friday, 27'th May 2022 Zacks Investment Research
Exelixis (EXEL) phase II study evaluating Cabometyx in combination with Keytruda in patients with recurrent or metastatic head and neck squamous cell carcinoma meets primary goal.
Pharma Stock Roundup: EU Nod for AZN, JNJ & Others, PFE COVID Jab Effective in Kids
01:29pm, Friday, 27'th May 2022 Zacks Investment Research
European Commission authorizes a booster dose of AstraZeneca's (AZN) COVID-19 vaccine and approves Merck (MRK) and Roche's (RHHBY) oncology drugs for expanded use.
Why This Fast-Growing Dividend Stock Is a Buy
10:45am, Friday, 27'th May 2022
Merck's market-topping 3% dividend yield isn't the sole reason to buy shares.
Better Dividend Stock: Pfizer or Merck?
10:04am, Thursday, 26'th May 2022 The Motley Fool
It's a close call between these two big drugmakers.
Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022?
09:57am, Thursday, 26'th May 2022 The Motley Fool
The legendary investor just might regret selling this big-pharma stock.
Better Dividend Stock: Pfizer or Merck?
06:04am, Thursday, 26'th May 2022
It's a close call between these two big drugmakers.
CDC: A Paxlovid rebound may be ‘natural’ part of a COVID-19 infection
02:45pm, Wednesday, 25'th May 2022 MarketWatch
The public-health agency continues to recommend the antiviral.
2 Top Biotech Stocks to Buy in May
02:15pm, Wednesday, 25'th May 2022 The Motley Fool
Despite the market sell-off, these biotech stocks have held up exceptionally well.
3 Unstoppable Investments Everyone Needs in Their Portfolio
01:00pm, Wednesday, 25'th May 2022 The Motley Fool
It's a bold word to describe them, but some companies really are in businesses bigger than any economic headwind.
Merck (MRK) Keytruda Gets EU Nod for Expanded Breast Cancer Use
12:35pm, Wednesday, 25'th May 2022 Zacks Investment Research
The European Commission approves Merck's (MRK) Keytruda for high-risk early-stage TNBC, which expands its eligible patient population.
Merck: Investment Opportunity
12:00pm, Wednesday, 25'th May 2022
Lagevrio sales for COVID-19 were $3247 million in Q1 2022. Merck's gross profit was $10,567 million in the first quarter, up 39.2% year-over-year.
2 Top Biotech Stocks to Buy in May
10:15am, Wednesday, 25'th May 2022
Despite the market sell-off, these biotech stocks have held up exceptionally well.
Merck (MRK) Keytruda Gets EU Nod for Expanded Breast Cancer Use
10:02am, Wednesday, 25'th May 2022
The European Commission approves Merck's (MRK) Keytruda for high-risk early-stage TNBC, which expands its eligible patient population.
